Neonatal early-onset Escherichia coli disease: The effect of intrapartum ampicillin

Archives of Pediatrics and Adolescent Medicine

Volumn 152, Issue 1, 1998, Pages 35-40

  Joseph, Tessy A ^a   Pyati, Suma P ^a,b   Jacobs, Norman ^a,c  

^a Jr Hospital of Cook County   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; ESCHERICHIA COLI; HUMAN; INFECTION PREVENTION; MATERNAL CARE; NEWBORN; NEWBORN INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION;

AGE OF ONSET; AMPICILLIN; AMPICILLIN RESISTANCE; CHICAGO; ESCHERICHIA COLI INFECTIONS; FEMALE; FEVER; GENTAMICINS; HUMANS; INFANT, NEWBORN; MALE; PENICILLINS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TREATMENT OUTCOME;

EID: 0031885178     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Freiz BJ, McCracken GH Jr. Acute infections. In: Avery GB, Fletcher MA, MacDonald MG, eds. Neonatology, Pathophysiology and Management of the Newborn. Philadelphia, Pa: JB Lippincott; 1994:1082-1116.
2. Klein JO, Marcy SM. Bacterial sepsis and meningitis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia, Pa: WB Saunders Co; 1990:601-665.
3. Sarff LD, McCracken GH Jr, Schiffer MS, et al. Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet. 1975;1:1099-1104.
4. Freedman RM, Ingram DL, Gross l, Ehrenkranz RA, Warshaw JB, Baltimore RS. A half century of neonatal sepsis at Yale. Am J Dis Child. 1981;135:140-144.
5. Placzek MM, Whitelaw A. Early and late neonatal septicemia. Arch Dis Child. 1983;58:728-731.
6. Bradley JS. Neonatal infections. Pediatr Infect Dis J. 1985;4:315-320.
7. Speck WT, Aronoff SC, Fanaroff AA. Neonatal infections. In: Klaus MH, Fanaroff AA, eds. Care of the High-Risk Neonate. Philadelphia, Pa: WB Saunders Co; 1986:262-285.
8. Gladstone IM, Ehrenkranz RA, Edberg SC, Baltimore RS. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J. 1990;9:819-825.
9. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986;314:1165-1169.
10. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal infections by chemoprophylaxis. Pediatrics. 1992;90:775-778.
11. American College of Obstetricians and Gynecologists. Group B Streptococcal Infections in Pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 1992. ACOG technical bulletin 170.
12. Pyati SP, Pildes RS, Jacobs NM, et al. Penicillin in infants weighing two kilograms or less with early-onset group B streptococcal disease. N Engl J Med. 1983;308:1383-1389.
13. Pyati SP, Pildes RS, Jacobs NM. Neonatal group B streptococcal disease (GBS). Pediatr Res. 1993;33:270A. Abstract.
14. Weisman LE, Stroll BJ, Cruess DF, et al. Early-onset group B streptococcal sepsis: a current assessment. J Pediatr. 1992;121:428-433.
15. Yagupsky P, Menegus MA, Powell KR. The changing spectrum of group B streptococcal disease in infants: an eleven-year experience in a tertiary care hospital. Pediatr Infect Dis J. 1991;10:801-808.
16. McDuffie RS Jr, McGregor JA, Gibbs RS. Adverse perinatal outcome and resistant enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage. Obstet Gynecol. 1993;82:487-489.
17. Maxwell GL, Watson WJ. Preterm premature rupture of membranes: results of expectant management in patients with cervical cultures positive for group B streptococcus or Neisseria gonorrhoea. Am J Obstet Gynecol. 1992;166:945-949.
18. Gibbs RS. Duff P: Progress in pathogenesis and management of clinical intraamniotic infection. Am J Obstet Gynecol. 1991;164:1317-1326.
19. Gerber AU, Vastola P, Brandel J, Craig WA. Selection of aminoglycosideresistant variants of Pseudomonas aeruginosa in an in vivo model. J Infect Dis. 1982;146:691-697.
20. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Morb Mortal Wkly Rep. 1996;45(RR-7):1-24.
21. American College of Obstetricians and Gynecologists. Prevention of early-onset group B streptococcal disease in newborns. ACOG Comm Opin. 1996;173:1-8.
22. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal infection by chemoprophylaxis. Pediatrics. 1997;99:489-496.